180 related articles for article (PubMed ID: 37119048)
1. Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use.
Schut AW; de Bruin LE; de Rooij BH; Lidington E; Timbergen MJM; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Gennatas S; Verhoef C; Husson O
Cancer Med; 2023 Jun; 12(12):13661-13674. PubMed ID: 37119048
[TBL] [Abstract][Full Text] [Related]
2. Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes.
Schut AW; Lidington E; Timbergen MJM; Younger E; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Verhoef C; Gennatas S; Husson O
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740642
[TBL] [Abstract][Full Text] [Related]
3. The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort Study.
Schut AW; Timbergen MJM; Lidington E; Grünhagen DJ; van der Graaf WTA; Sleijfer S; van Houdt WJ; Bonenkamp JJ; Younger E; Dunlop A; Jones RL; Verhoef C; Gennatas S; Husson O
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206149
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life (HRQoL), anxiety, and depression in patients with desmoid type fibromatosis.
Garg V; Rastogi S; Kalra K; Bhoriwal S; Barwad A; Dhamija E; Upadhyay A; Gamangatti S
Support Care Cancer; 2022 Dec; 30(12):10089-10098. PubMed ID: 36350382
[TBL] [Abstract][Full Text] [Related]
5. Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis.
Schut AW; Lidington E; Timbergen MJM; Younger E; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Verhoef C; Gennatas S; Husson O
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158976
[TBL] [Abstract][Full Text] [Related]
6. Health-related Quality of Life of Patients With Non-Intra-abdominal Desmoid-Type Fibromatosis During Active Surveillance: Results of a Prospective Observational Study.
Schut AW; Timbergen MJM; Nasserinejad K; van Dalen T; van Houdt WJ; Bonenkamp JJ; Sleijfer S; Grünhagen DJ; Verhoef C; Husson O;
Ann Surg; 2023 Jun; 277(6):877-883. PubMed ID: 36727954
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Desmoid-Type Fibromatosis Patients' Voice: Comparison of Health-Related Quality of Life Experiences from Patients of Two Countries.
Timbergen MJM; van der Graaf WTA; Grünhagen DJ; Younger E; Sleijfer S; Dunlop A; Dean L; Verhoef C; van de Poll-Franse LV; Husson O
Sarcoma; 2020; 2020():2141939. PubMed ID: 32774131
[TBL] [Abstract][Full Text] [Related]
8. Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study.
Timbergen MJM; van de Poll-Franse LV; Grünhagen DJ; van der Graaf WT; Sleijfer S; Verhoef C; Husson O
Qual Life Res; 2018 Dec; 27(12):3097-3111. PubMed ID: 30014458
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy.
Weidema ME; Husson O; van der Graaf WTA; Leonard H; de Rooij BH; Hartle DeYoung L; Desar IME; van de Poll-Franse LV
Acta Oncol; 2020 Aug; 59(8):975-982. PubMed ID: 32476528
[No Abstract] [Full Text] [Related]
10. Functional analysis of young patients with desmoid-type fibromatosis: Initial surveillance does not jeopardize long term quality of life.
Duhil de Bénazé G; Vigan M; Corradini N; Minard-Colin V; Marie-Cardine A; Verite C; Defachelles AS; Thebaud E; Castex MP; Sirvent N; Bodet D; Mansuy L; Rome A; Petit A; Plantaz D; Jourdain A; Mary P; Carton M; Orbach D
Eur J Surg Oncol; 2020 Jul; 46(7):1294-1300. PubMed ID: 32173177
[TBL] [Abstract][Full Text] [Related]
11. GOunder/Desmoid Tumor Research Foundation DEsmoid Symptom/Impact Scale (GODDESS
Gounder MM; Atkinson TM; Bell T; Daskalopoulou C; Griffiths P; Martindale M; Smith LM; Lim A
Qual Life Res; 2023 Oct; 32(10):2861-2873. PubMed ID: 37347393
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study.
Kang D; Kim S; Kim H; Lee M; Kong SY; Chang YJ; Sim SH; Kim YJ; Cho J
JMIR Public Health Surveill; 2023 Mar; 9():e44105. PubMed ID: 36884274
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials in desmoid-type fibromatosis in children and adults: A systematic review.
van Maren SA; van Noesel MM; Husson O; van der Graaf WTA
Pediatr Blood Cancer; 2022 Sep; 69(9):e29831. PubMed ID: 35714333
[TBL] [Abstract][Full Text] [Related]
14. Desmoid fibromatosis through the patients' eyes: time to change the focus and organisation of care?
Husson O; Younger E; Dunlop A; Dean L; Strauss DC; Benson C; Hayes AJ; Miah A; van Houdt W; Zaidi S; Smith M; Williams J; Jones RL; van der Graaf WTA
Support Care Cancer; 2019 Mar; 27(3):965-980. PubMed ID: 30155568
[TBL] [Abstract][Full Text] [Related]
15. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
[TBL] [Abstract][Full Text] [Related]
16. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular choristoma-associated desmoid-type fibromatosis: Establishing a nerve territory concept.
Maldonado AA; Spinner RJ; Broski SM; Stone JJ; Howe BM; Carter JM
Acta Neurochir (Wien); 2020 May; 162(5):1137-1146. PubMed ID: 31897730
[TBL] [Abstract][Full Text] [Related]
18. Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort.
de Ligt KM; de Rooij BH; Walraven I; Heins MJ; Verloop J; Siesling S; Korevaar JC; van de Poll-Franse LV
Support Care Cancer; 2022 Oct; 30(10):7873-7883. PubMed ID: 35727375
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life and associated factors among cervical cancer patients at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
Araya LT; Fenta TG; Sander B; Gebremariam GT; Gebretekle GB
Health Qual Life Outcomes; 2020 Mar; 18(1):72. PubMed ID: 32178681
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose.
Garg V; Gangadharaiah BB; Rastogi S; Upadhyay A; Barwad A; Dhamija E; Gamangatti S
Eur J Cancer; 2023 Jun; 186():142-150. PubMed ID: 37062211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
